Literature DB >> 18444231

Colchicinoids from Colchicum crocifolium Boiss.: a case study in dereplication strategies for (-)-colchicine and related analogues using LC-MS and LC-PDA techniques.

Feras Q Alali1, Ahmad Gharaibeh, Abdullah Ghawanmeh, Khaled Tawaha, Nicholas H Oberlies.   

Abstract

As a part of a project designed to investigate Colchicum species in Jordan, the chemical constituents of Colchicum crocifolium Boiss. (Colchicaceae) were investigated using LC-MS and LC-UV/Vis PDA. A decision tree for working with colchicinods has been developed by incorporating data from LC-UV/PDA and LC-MS. This dereplication strategy draws upon the UV/PDA spectra to classify compounds into one of four structural groups and combines this with retention time and mass spectra/molecular weight to identify the compounds. This strategy was applied on a small amount of extract (2 mg) of Colchicum crocifolium to dereplicate 10 known compounds from four different structural groups, namely (-)-demecolcine, 2-demethyl-(-)-colchicine or 3-demethyl-(-)-colchicine, N-deacetyl-(-)-colchicine, (-)-colchiciline, (-)-colchicine, beta-lumidemecolcine, 2-demethyl-beta-lumicolchicine or 3-demethyl-beta-lumicolchicine, N,N-dimethyl-N-deacetyl-beta-lumicornigerine, (-)-isoandrocymbine and (-)-autumnaline. Furthermore, a new compound was identi?ed as N,N-dimethyl-N-deacetyl-(-)-cornigerine. Three compounds, which had molecular ions at m/z 325, 340 and 374, could not be dereplicated into any obvious structural classes that have been isolated in our laboratories previously or reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444231     DOI: 10.1002/pca.1060

Source DB:  PubMed          Journal:  Phytochem Anal        ISSN: 0958-0344            Impact factor:   3.373


  7 in total

1.  Proliferation of antibiotic-producing bacteria and concomitant antibiotic production as the basis for the antibiotic activity of Jordan's red soils.

Authors:  Joseph O Falkinham; Thomas E Wall; Justin R Tanner; Khaled Tawaha; Feras Q Alali; Chen Li; Nicholas H Oberlies
Journal:  Appl Environ Microbiol       Date:  2009-03-13       Impact factor: 4.792

2.  High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products.

Authors:  Tamam El-Elimat; Mario Figueroa; Brandie M Ehrmann; Nadja B Cech; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Nat Prod       Date:  2013-08-16       Impact factor: 4.050

3.  Mapping of Sample Collection Data: GIS Tools for the Natural Product Researcher.

Authors:  Nicholas H Oberlies; James I Rineer; Feras Q Alali; Khaled Tawaha; Joseph O Falkinham; William D Wheaton
Journal:  Phytochem Lett       Date:  2009-02-19       Impact factor: 1.679

4.  Cytotoxic homoisoflavonoids from the bulbs of Bellevalia flexuosa.

Authors:  Tamam El-Elimat; José Rivera-Chávez; Joanna E Burdette; Austin Czarnecki; Maram B Alhawarri; Mohammad Al-Gharaibeh; Feras Alali; Nicholas H Oberlies
Journal:  Fitoterapia       Date:  2018-02-20       Impact factor: 2.882

Review 5.  Reviewing Colchicaceae alkaloids - perspectives of evolution on medicinal chemistry.

Authors:  Sonny Larsson; Nina Rønsted
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

Review 6.  Discovery and resupply of pharmacologically active plant-derived natural products: A review.

Authors:  Atanas G Atanasov; Birgit Waltenberger; Eva-Maria Pferschy-Wenzig; Thomas Linder; Christoph Wawrosch; Pavel Uhrin; Veronika Temml; Limei Wang; Stefan Schwaiger; Elke H Heiss; Judith M Rollinger; Daniela Schuster; Johannes M Breuss; Valery Bochkov; Marko D Mihovilovic; Brigitte Kopp; Rudolf Bauer; Verena M Dirsch; Hermann Stuppner
Journal:  Biotechnol Adv       Date:  2015-08-15       Impact factor: 14.227

7.  A New Insight into Toxicity of Colchicine Analogues by Molecular Docking Analysis Based on Intestinal Tight Junction Protein ZO-1.

Authors:  Jiali Liu; Rongrong Gao; Xuejing Gu; Bin Yu; Yan Wu; Qiushi Li; Ping Xiang; Hui Xu
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.